神経機器市場：製品別、エンドユーザー別-2025-2030年の世界予測

神経機器市場は、2023年に94億6,000万米ドルと評価され、2024年には101億米ドルに達すると予測され、CAGR 7.81％で成長し、2030年には160億3,000万米ドルに達すると予測されています。

神経機器は、神経障害の診断、モニタリング、治療を目的とした多様な医療技術を指し、神経刺激ツール、神経外科器具、神経診断装置などの機器を含むが、これらに限定されるものではないです。このような機器の必要性は、アルツハイマー病、パーキンソン病、てんかん、外傷性損傷などの神経疾患の有病率の上昇によって強調されており、効果的な治療と管理のための高度なソリューションが必要とされています。調査用途は病院、診療所、研究機関など多岐にわたり、最終用途には医療提供者と生活の質の向上を求める患者の両方が含まれます。この市場は、老人人口の増加、生物工学やAIの進歩、神経疾患に対する意識の高まりといった要因の影響を受けています。現在、遠隔医療やモバイルヘルスアプリなどのデジタルヘルス技術を神経機器と組み合わせることで、患者の予後を改善する潜在的なビジネスチャンスが生まれています。しかし、市場は神経機器の高コスト、厳しい規制シナリオ、神経疾患の複雑さなどの限界に直面しています。さらに、COVID-19の大流行がサプライチェーンの問題を悪化させ、市場の成長をさらに困難なものにしています。こうしたハードルにもかかわらず、技術革新の見通しは有望であり、特に個別化医療、診断ツールの改善、非侵襲性デバイスの開発といった分野では有望です。ブレイン・コンピューター・インターフェイスやウェアラブル技術の調査も、大きな成長機会をもたらしています。企業は、テクノロジー企業との協業に注力し、新製品開発のための研究開発に投資することで、競争の激しい市場の本質を洞察することができます。ヘルスケアプロバイダーとの提携を通じて製品の認知度とアクセシビリティを高め、強力なマーケティング戦略を展開し、規制へのコンプライアンスを徹底することが、新たな機会を効果的に捉えるための極めて重要な戦略です。

市場力学：急速に進化する神経機器市場の主要市場インサイトを公開

神経機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の神経疾患の流行
  • 低侵襲手技への傾斜
  • 疾患の早期診断と治療に対する意識の高まり
• 市場抑制要因
  • 高コストと製品回収の発生
• 市場機会
  • 個別化医療と遠隔医療の新たな動向
  • 革新的な神経機器を開発するための継続的な研究開発
• 市場の課題
  • 製造の複雑さと安全性への懸念

ポーターの5つの力：神経機器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、神経機器市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経機器市場における外部からの影響の把握

外部マクロ環境要因は、神経機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析神経機器市場における競合情勢の把握

神経機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス神経機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨神経機器市場における成功への道筋を描く

神経機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中の神経疾患の有病率
    • 低侵襲手術への傾向
    • 病気の早期診断と治療に関する意識の高まり
  • 抑制要因
    • 高額なコストと製品リコールの発生
  • 機会
    • パーソナライズ医療と遠隔医療の新たなトレンド
    • 革新的な神経機器を開発するための継続的な研究開発
  • 課題
    • 製造の複雑さと安全性の懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 神経機器市場：製品別

• 脳脊髄液管理装置
  • 脳脊髄液シャント
  • 外部排水システム
• 介入的神経機器
  • アクセサリデバイス
  • 塞栓保護デバイス
  • 塞栓デバイス
  • 血行再建デバイス
  • 血栓除去装置
• 神経刺激装置
  • 脳深部刺激装置
  • 仙骨神経刺激装置
  • 脊髄刺激装置
  • 迷走神経刺激装置
• 脳神経外科用機器
  • 神経内視鏡検査
  • 脳神経外科ナビゲーション

第7章 神経機器市場：エンドユーザー別

• 外来手術センター
• 病院

第8章 南北アメリカの神経機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の神経機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの神経機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acandis GmbH
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Esaote SpA
• GE HealthCare Technologies, Inc.
• Integra LifeSciences Holdings
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• LivaNova PLC
• Masimo Corporation
• Medtronic PLC
• MicroPort Scientific Corporation
• Natus Medical Inc.
• Nihon Kohden Corporation
• Penumbra Inc.
• Perflow Medical
• Rapid Medical Ltd.
• Siemens Healthcare GmbH
• Smith & Nephew plc
• Stryker Corporation
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Zimmer Biomet Holding Inc.

LIST OF FIGURES

• FIGURE 1. NEUROLOGY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROLOGY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROLOGY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF SHUNTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EXTERNAL DRAINAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIZATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REVASCULARIZATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY NAVIGATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. CANADA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 53. CANADA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 54. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 56. CANADA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. CHINA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. CHINA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 85. CHINA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 86. CHINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. CHINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. CHINA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. INDIA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. INDIA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. INDIA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. INDIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 93. INDIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 94. INDIA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. ITALY NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. ITALY NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. ITALY NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 195. ITALY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. ITALY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 197. ITALY NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 216. POLAND NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. POLAND NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. POLAND NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 219. POLAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 220. POLAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 221. POLAND NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. QATAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. QATAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 224. QATAR NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 225. QATAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 226. QATAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 227. QATAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM NEUROLOGY DEVICES MARKET SIZE, BY CEREBROSPINAL FLUID MANAGEMENT DEVICES, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY DEVICES, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION DEVICES, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 282. NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 283. NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Neurology Devices Market was valued at USD 9.46 billion in 2023, expected to reach USD 10.10 billion in 2024, and is projected to grow at a CAGR of 7.81%, to USD 16.03 billion by 2030.

Neurology devices refer to a diverse range of medical technologies designed to diagnose, monitor, and treat neurological disorders, encompassing but not limited to devices such as neurostimulation tools, neurosurgery instruments, and neurodiagnostic equipment. The necessity of such devices is underscored by the rising prevalence of neurological diseases such as Alzheimer's, Parkinson's, epilepsy, and traumatic injuries, which necessitate advanced solutions for effective treatment and management. Applications of neurology devices span across hospitals, clinics, and research institutions, and the end-use scope includes both healthcare providers and patients seeking improved quality of life. The market is influenced by factors such as the increasing geriatric population, advances in bioengineering and AI, and heightened awareness of neurological conditions. Currently, potential opportunities arise from the integration of digital health technologies, such as telemedicine and mobile health apps, paired with neurology devices to enhance patient outcomes. However, the market faces limitations like high costs of neurology devices, stringent regulatory scenarios, and the complexity of neurological disorders. Additionally, the Covid-19 pandemic has exacerbated supply chain issues, further challenging market growth. Despite these hurdles, innovation prospects are promising, especially in areas like personalized medicine, improved diagnostic tools, and the development of non-invasive devices. Research into brain-computer interfaces and wearable technologies also offers significant growth opportunities. Businesses can gain insights into the nature of a highly competitive market by focusing on collaborative efforts with technology companies and investing in R&D for new product development. Elevating product awareness and accessibility through partnerships with healthcare providers, robust marketing strategies, and ensuring compliance with regulations are pivotal strategies to capture emerging opportunities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurology Devices Market

The Neurology Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of neurological disorders worldwide
  • Inclination towards minimally invasive procedures
  • Growing awareness regarding early diagnosis and treatment of diseases
• Market Restraints
  • High cost and incidences of product recall
• Market Opportunities
  • Emerging trend of personalized medicine and telemedicine
  • Ongoing R&D to develop innovative neurology devices
• Market Challenges
  • Complexity in manufacturing and safety concerns

Porter's Five Forces: A Strategic Tool for Navigating the Neurology Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurology Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurology Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurology Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurology Devices Market

A detailed market share analysis in the Neurology Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurology Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurology Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurology Devices Market

A strategic analysis of the Neurology Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurology Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Esaote SpA, GE HealthCare Technologies, Inc., Integra LifeSciences Holdings, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., LivaNova PLC, Masimo Corporation, Medtronic PLC, MicroPort Scientific Corporation, Natus Medical Inc., Nihon Kohden Corporation, Penumbra Inc., Perflow Medical, Rapid Medical Ltd., Siemens Healthcare GmbH, Smith & Nephew plc, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., and Zimmer Biomet Holding Inc..

Market Segmentation & Coverage

This research report categorizes the Neurology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurostimulation Devices, and Neurosurgery Devices. The Cerebrospinal Fluid Management Devices is further studied across CSF Shunts and External Drainage System. The Interventional Neurology Devices is further studied across Accessory Devices, Embolic Protection Devices, Embolization Devices, Revascularization Devices, and Thrombectomy Devices. The Neurostimulation Devices is further studied across Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, and Vagus Nerve Stimulators. The Neurosurgery Devices is further studied across Neuroendoscopy and Neurosurgery Navigations.
• Based on End User, market is studied across Ambulatory Surgery Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of neurological disorders worldwide
    • 5.1.1.2. Inclination towards minimally invasive procedures
    • 5.1.1.3. Growing awareness regarding early diagnosis and treatment of diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and incidences of product recall
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging trend of personalized medicine and telemedicine
    • 5.1.3.2. Ongoing R&D to develop innovative neurology devices
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity in manufacturing and safety concerns
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurology Devices Market, by Product

• 6.1. Introduction
• 6.2. Cerebrospinal Fluid Management Devices
  • 6.2.1. CSF Shunts
  • 6.2.2. External Drainage System
• 6.3. Interventional Neurology Devices
  • 6.3.1. Accessory Devices
  • 6.3.2. Embolic Protection Devices
  • 6.3.3. Embolization Devices
  • 6.3.4. Revascularization Devices
  • 6.3.5. Thrombectomy Devices
• 6.4. Neurostimulation Devices
  • 6.4.1. Deep Brain Stimulators
  • 6.4.2. Sacral Nerve Stimulators
  • 6.4.3. Spinal Cord Stimulators
  • 6.4.4. Vagus Nerve Stimulators
• 6.5. Neurosurgery Devices
  • 6.5.1. Neuroendoscopy
  • 6.5.2. Neurosurgery Navigations

7. Neurology Devices Market, by End User

• 7.1. Introduction
• 7.2. Ambulatory Surgery Centers
• 7.3. Hospitals

8. Americas Neurology Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Neurology Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Neurology Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acandis GmbH
• 3. B. Braun Melsungen AG
• 4. Becton, Dickinson and Company
• 5. Boston Scientific Corporation
• 6. Esaote SpA
• 7. GE HealthCare Technologies, Inc.
• 8. Integra LifeSciences Holdings
• 9. Johnson & Johnson Services, Inc.
• 10. Koninklijke Philips N.V.
• 11. LivaNova PLC
• 12. Masimo Corporation
• 13. Medtronic PLC
• 14. MicroPort Scientific Corporation
• 15. Natus Medical Inc.
• 16. Nihon Kohden Corporation
• 17. Penumbra Inc.
• 18. Perflow Medical
• 19. Rapid Medical Ltd.
• 20. Siemens Healthcare GmbH
• 21. Smith & Nephew plc
• 22. Stryker Corporation
• 23. Terumo Corporation
• 24. W. L. Gore & Associates, Inc.
• 25. Zimmer Biomet Holding Inc.